Scynexis (SCYX) Capital Expenditures (2013 - 2021)
Scynexis' (SCYX) quarterly Capital Expenditures came in at -$478000.0 in Q4 2021, down 11850.0% YoY from N/an in Q4 2020, and down 303.4% on a QoQ basis from $235000.0 in Q3 2021.
Scynexis (SCYX) Capital Expenditures (2013 - 2021) Analysis & Trends
Scynexis (SCYX) has 8 years of Capital Expenditures data on file, last reported at -$478000.0 in Q4 2021.
- Quarterly Capital Expenditures fell 11850.0% year-over-year to -$478000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was -$478000.0 (down 186.59% YoY) and the FY2021 annual result came in at $78000.0, changed N/A from the prior year.
- Capital Expenditures fell to -$478000.0 in Q4 2021, from $235000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $400000.0 in Q2 2018 to a low of -$478000.0 in Q4 2021.
- A 4-year average of $58636.4 and a median of $67000.0 in 2018 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 5775.0% in 2021, down 11850.0% in 2021.
- Tracing SCYX's Capital Expenditures over 4 years: stood at $2000.0 in 2017, then soared by 4300.0% to $88000.0 in 2018, then plunged by 104.55% to -$4000.0 in 2020, then slumped by 11850.0% to -$478000.0 in 2021.
- The last three Capital Expenditures figures came in at -$478000.0 (Q4 2021), $235000.0 (Q3 2021), and $143000.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -478,000.00 |
| Dec 31, 2021 | -478,000.00 |
| Sep 30, 2021 | 235,000.00 |
| Sep 30, 2021 | 235,000.00 |
| Jun 30, 2021 | 143,000.00 |
| Jun 30, 2021 | 143,000.00 |
| Mar 31, 2021 | 178,000.00 |
| Mar 31, 2021 | 178,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Dec 31, 2018 | 88,000.00 |
| Dec 31, 2018 | 88,000.00 |
| Sep 30, 2018 | 67,000.00 |
| Sep 30, 2018 | 67,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Mar 31, 2018 | 10,000.00 |
| Mar 31, 2018 | 10,000.00 |